Project Grant HT9425261E362
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $1M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
South Miami, FL 33146, USA
Similar Awards
- Federal Project Grant Award Summary The University of Miami, Office of Research Administration - School of Medicine, received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded June 1, 2026, with an ultimate completion date of May 31, 2029. The award supports the development of a Schwann cell-derived extracellular vesicle platform for amyotrophic lateral sclerosis (ALS) biomarker discovery in biofluids....
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded the University of Miami's Office of Research Administration - School of Medicine Division a $602,841 Project Grant under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2026, with completion scheduled for June 14, 2030. The project, titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," focuses on advancing...
- Federal Project Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine Division received a $1,092,670 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded June 15, 2026, with completion targeted for June 14, 2030. The project, titled "Bringing Alzheimer's Detection to the Front Lines: Evaluating Novel Cognitive and Plasma Biomarkers in Primary Care," supports...
- This Project Grant award of $894,330.00 from the U.S. Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is funding research conducted by the University of Miami to investigate "Targeting Axonal Regeneration Pathways as a Therapeutic Approach to ALS." The project aims to transform healthcare for military service members and the broader public by advancing biomedical research into innovative medical solutions for critical health challenges. The award...
- Federal Grant Award Summary New York University School of Medicine received a $1.0 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective June 1, 2026 through May 31, 2029. The award supports research on diffusion magnetic resonance imaging (MRI) biomarkers of axonal degeneration in amyotrophic lateral sclerosis (ALS). The research will be conducted at NYU's facility in New York, NY, and is expected to...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the Regents of the University of Michigan a $838,945 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through June 30, 2028. The project, titled "Addressing TDP43-Dependent Disease Mechanisms in ALS Through Selective Pharmacological Cochaperones," supports basic and applied biomedical research focused on amyotrophic lateral sclerosis (ALS), a...
- Grant Award Summary The University of Miami's Office of Research Administration - School of Medicine received a $490,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded July 1, 2026, with completion targeted for June 30, 2028. The project, titled "Elucidation of Metabolic-Epigenetic Rewiring in Chordoma," supports basic and applied biomedical research investigating the molecular mechanisms underlying...
- Federal Project Grant Award Summary Arizona State University received a $962,713 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2025, with a completion date of June 14, 2028. The award supports research focused on developing robust subtype markers for amyotrophic lateral sclerosis (ALS) patient stratification. This initiative aligns with the DHA's mission to advance biomedical research that transforms...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $840,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2026, with an ultimate completion date of May 31, 2028. The award funds investigative research examining the hyperphosphorylation of tau serine 262 as a novel biomarker and potential therapeutic target in amyotrophic lateral sclerosis (ALS). This research aligns with the DHA's...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded $770K to the South Florida Veterans Affairs Foundation For Research And Education, Inc. under the Military Medical Research and Development program (CFDA 12.420) to conduct a three-year research project running from August 1, 2026 through July 31, 2029. The project, titled "Sphingolipids and Eicosanoids from Plasma and Tear Fluid as Disease-Relevant Biomarkers in Gulf War Illness," seeks to identify and validate...